Teplizumab Approval Expands to Early Type 1 Diabetes

(MedPage Today) -- The FDA expanded the approval of teplizumab (Tzield) to include pediatric patients 8 years and older who have recently been diagnosed with stage 3 type 1 diabetes, the clinical stage where hyperglycemia symptoms emerge and insulin...